Follow:
RSS
Email
Twitter
Curaxis Pharmaceutical Corp. :: Alzheimer's News, Insight, and Information
  • Home
  • About Us
  • Media
  • Uncategorized

Archive for April, 2010

  • AAN Issues Guideline on When People With Alzheimer’s Disease Should Stop Driving: Presented at AAN on April 14th, 2010
  • Emotions Outlast The Memories That Drive Them on April 14th, 2010
  • Copper & Iron Linked To Alzheimer’s, Heart Disease, And Aging In General on April 8th, 2010
  • Pfizer Sees ‘Golden Age’ in Alzheimer’s, Cancer Drugs on April 8th, 2010
  • Simple Memory Test May Detect Early Alzheimer’s on April 8th, 2010
  • A drug that extends life span prevents Alzheimer’s deficits on April 6th, 2010
  • Alzheimer’s rat created for human research on April 6th, 2010
  • Self-test for memory disorders designed on April 1st, 2010
  • Many with Alzheimer’s get depression drug on April 1st, 2010
Newer Entries »

  • Recent Articles

    • Alzheimer’s brain tangles offer clue to worsening
    • Cognitive Impairment Strikes Men More
    • Exercise Protects Against Alzheimer’s
    • Spinal taps may be useful in predicting brain disorders
    • New Study Explores Link Between Type 2 Diabetes, Alzheimer’s
  • Categories

  • Archives

    • September 2010 (3)
    • August 2010 (11)
    • July 2010 (17)
    • June 2010 (20)
    • May 2010 (20)
    • April 2010 (19)
    • March 2010 (16)
    • February 2010 (8)
    • January 2010 (16)
    • December 2009 (17)
    • November 2009 (1)
  • Curaxis Pharmaceutical Corp.

    Curaxis Pharmaceutical Corporation is a specialty company dedicated to finding cures for major age-related diseases with it initial focus is Alzheimer’s Disease (or AD). For more, visit www.curaxispharma.com

  • Follow Us On Twitter

    • News:: New Study Explores Link Between Type 2 Diabetes, Alzheimer's http://bit.ly/bDgU67
    • News:: Alzheimer's drug could put the brakes on deadly disease http://bit.ly/dgEAY0
    • News:: New Alzheimer's test http://blog.curaxispharma.com/2010/08/17/new-alzheimers-test/

About

Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Our initial focus is Alzheimer’s Disease (or AD). Our lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer’s Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease.
  • Videos

Search

Copyright © 2012 Curaxis Pharmaceutical Corp.